Bryan Spencer1. 1. American Red Cross, New England Region, Dedham, Massachusetts, USA.
Abstract
PURPOSE OF REVIEW: This review examines the recent research on the prevalence, determinants and importance of low iron in blood donors, and on the efforts to reduce or prevent iron depletion in donor populations. RECENT FINDINGS: Female donors, especially younger women, are at highest risk for donation-induced low iron, but menopausal women and high-frequency donors of both sexes also face considerable risk for iron depletion. Predonation screening for hemoglobin contributes little information on donor iron status. Consumption of supplemental iron is helpful in preventing or reversing low iron, and waiting longer between donations also facilitates the recovery of the iron lost through donation. SUMMARY: Although the impact of phlebotomy-related iron depletion on donor health requires better documentation, measures are available now that can be deployed on a targeted or standardized basis. Blood centers, regulators, and donors should continue to evaluate different approaches for addressing this problem, with the likely outcome that no single measure is optimal for maintaining adequate collections while safeguarding donor health.
PURPOSE OF REVIEW: This review examines the recent research on the prevalence, determinants and importance of low iron in blood donors, and on the efforts to reduce or prevent iron depletion in donor populations. RECENT FINDINGS: Female donors, especially younger women, are at highest risk for donation-induced low iron, but menopausal women and high-frequency donors of both sexes also face considerable risk for iron depletion. Predonation screening for hemoglobin contributes little information on donoriron status. Consumption of supplemental iron is helpful in preventing or reversing low iron, and waiting longer between donations also facilitates the recovery of the iron lost through donation. SUMMARY: Although the impact of phlebotomy-related iron depletion on donor health requires better documentation, measures are available now that can be deployed on a targeted or standardized basis. Blood centers, regulators, and donors should continue to evaluate different approaches for addressing this problem, with the likely outcome that no single measure is optimal for maintaining adequate collections while safeguarding donor health.
Authors: Ritchard G Cable; Simone A Glynn; Joseph E Kiss; Alan E Mast; Whitney R Steele; Edward L Murphy; David J Wright; Ronald A Sacher; Jerry L Gottschall; Leslie H Tobler; Toby L Simon Journal: Transfusion Date: 2011-10-24 Impact factor: 3.157
Authors: Alan E Mast; Karen S Schlumpf; David J Wright; Brian Custer; Bryan Spencer; Edward L Murphy; Toby L Simon Journal: Transfusion Date: 2010-04-15 Impact factor: 3.157
Authors: A Mireille Baart; Paulus A H van Noord; Yvonne Vergouwe; Karel G M Moons; Dorine W Swinkels; Erwin T Wiegerinck; Wim L A M de Kort; Femke Atsma Journal: Transfusion Date: 2012-11-26 Impact factor: 3.157
Authors: Karen H C Lim; Alison O Booth; Caryl A Nowson; Ewa A Szymlek-Gay; David O Irving; Lynn J Riddell Journal: Nutrients Date: 2016-09-02 Impact factor: 5.717
Authors: Sara Moazzen; Maike G Sweegers; Mart Janssen; Boris M Hogema; Trynke Hoekstra; Katja Van den Hurk Journal: J Clin Med Date: 2022-06-21 Impact factor: 4.964
Authors: Maike G Sweegers; Saurabh Zalpuri; Franke A Quee; Elisabeth M J Huis In 't Veld; Femmeke J Prinsze; Emiel O Hoogendijk; Jos W R Twisk; Anton W M van Weert; Wim L A M de Kort; Katja van den Hurk Journal: Trials Date: 2020-10-01 Impact factor: 2.279